[Differential effect of glucosaminylmuramyl dipeptide on the phenotype of melanoma sublines with different metastatic potential].
Valiakina
T I
TI
Malakhov
A A
AA
Komaleva
R L
RL
Petrova
E E
EE
Mikhaĭlov
A D
AD
Revazova
E S
ES
Nesmeianov
V A
VA
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D008546:Melanoma, Experimental / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis / Q000235:genetics* / Q000276:immunology; D009368:Neoplasm Transplantation; D010641:Phenotype; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured; D019139:Tumor Escape
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000119:Acetylmuramyl-Alanyl-Isoglutamine